JinkoSolar Holding Co., Ltd. (NYSE:JKS), announced that its board of directors (the “Board”) passed resolutions approving: Mr. Haitao Jin’s resignation as a director from the Board and as a member of the compensation committee; The election of Mr. Longgen Zhang, the chief financial officer of the Company, as a director of the Board; and The election of Mr. Xiande Li, the chairman of the Board, to the compensation committee and to the position of chairperson of the compensation committee. JinkoSolar Holding Co., Ltd. (NYSE:JKS) net profit margin is 2.70% and weekly performance is 12.48%. On last trading day company shares ended up $25.86. Analysts mean target price for the company is $44.33. JinkoSolar Holding Co., Ltd. (NYSE:JKS) distance from 50-day simple moving average (SMA50) is -7.96%.
Cleveland Research said AutoZone, Inc. (NYSE:AZO)’s Q3 comp sales trends and earnings are tracking ahead of consensus driven by DIY momentum and commercial business. As a result, the firm raised its Q3 EPS estimate to $8.50 vs. consensus of $8.46 and FY14 to $31.58 vs. consensus of $31.52. AutoZone, Inc. (NYSE:AZO) shares fell -0.14% in last trading session and ended the day on $540.90. AZO Gross Margin is 51.90% and its return on assets is 15.00%. AutoZone, Inc. (NYSE:AZO) quarterly performance is -0.24%.
Durata Therapeutics Inc (NASDAQ:DRTX) announced that the FDA has approved Dalvance for injection for the treatment of adult patients with acute bacterial skin and skin structure infections caused by susceptible Gram-positive bacteria, including methicillin-resistant Staphylococcus aureus, or MRSA. Dalvance is the first and only IV antibiotic approved for the treatment of ABSSSI with a two-dose regimen of 1000 mg followed one week later by 500 mg, each administered over 30 minutes. Durata Therapeutics Inc (NASDAQ:DRTX) shares moved up 5.50% in last trading session and was closed at $16.89, while trading in range of $16.01 – $17.12. Durata Therapeutics Inc (NASDAQ:DRTX) year to date (YTD) performance is 32.06%.
After Tuesday’s market close, Workday Inc (NYSE:WDAY) will report first-quarter results, with analysts expecting the business-software maker to report a loss of 15 cents a share on revenue of $152 million. Workday Inc (NYSE:WDAY) ended the last trading day at $78.30. Company weekly volatility is calculated as 4.79% and price to cash ratio as 7.65. Workday Inc (NYSE:WDAY) showed a positive weekly performance of 9.11%.
Qihoo 360 Technology Co (NASDAQ:QIHU) will post its Q114 quarterly earnings results on Tuesday, May 27th. Analysts expect Qihoo 360 Technology Co to post earnings of $0.34 per share and revenue of $228.20 million for the quarter. Qihoo 360 Technology Co Ltd (NYSE:QIHU) shares moved up 1.17% in last trading session and was closed at $89.08, while trading in range of $85.76 – $89.36. Qihoo 360 Technology Co Ltd (NYSE:QIHU) year to date (YTD) performance is 8.57%.